December 16, 2019Open Access
Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia
Key Points
Key points are not available for this paper at this time.
Abstract
In chronic schizophrenia patients with acute exacerbations, doses higher than the identified 95% effective doses may on average not provide more efficacy. For some drugs, higher than currently licensed doses might be tested in further trials, because their dose-response curves did not plateau.